Related Experiment Video
Updated: Jun 22, 2026

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)
Published on: August 21, 2016
Peutz-Jeghers syndrome: genetic screening
Barbara A Leggett1, Joanne P Young, Melissa Barker
1Royal Brisbane Hospital, Herston 4029, Australia. barbara_leggett@health.qld.gov.au
Insights
Peutz-Jeghers syndrome causes gastrointestinal polyps and increases cancer risk. Genetic testing for STK11 mutations enables early diagnosis and improved outcomes through surveillance.
Area of Science:
- Genetics
- Oncology
- Gastroenterology
Background:
- Peutz-Jeghers syndrome (PJS) is an inherited disorder.
- It is characterized by hamartomatous polyps in the gastrointestinal tract.
- PJS significantly increases the risk of various cancers, including gastrointestinal, pancreatic, breast, and uterine malignancies.
Purpose of the Study:
- To highlight the clinical significance of Peutz-Jeghers syndrome.
- To emphasize the role of genetic testing in PJS management.
- To promote early surveillance for improved patient prognosis.
Main Methods:
- Review of PJS pathophysiology and clinical manifestations.
- Discussion of diagnostic and predictive genetic testing for STK11/LKB1 gene mutations.
- Emphasis on the implementation of surveillance programs.
Main Results:
- Identification of causative mutations in the serine/threonine kinase (STK)-11 (LKB1) gene.
- Genetic testing is now a routine clinical practice for PJS families.
- Early recognition of at-risk individuals is achievable.
Conclusions:
- Early surveillance programs are crucial for improving the prognosis of Peutz-Jeghers syndrome.
- Genetic testing for STK11/LKB1 mutations facilitates early diagnosis.
- Routine clinical application of genetic testing allows for timely intervention in affected families.
Abstract:
Peutz-Jeghers syndrome is an autosomal dominant condition leading to gastrointestinal polyps which often causes bowel obstruction. This syndrome also predisposes to gastrointestinal, pancreatic, breast, uterine and other malignancies. Prognosis is likely to be improved by the early commencement of appropriate surveillance programs. Diagnostic and predictive genetic testing is now possible in many families due to identification of causative mutations in the serine/threonine kinase (STK)-11 (also known as the LKB1) gene. Such testing has now entered routine clinical practice and will allow early recognition of the condition in young, at-risk family members.
Related Concept Videos
Polygenic Traits
Animal Mitochondrial Genetics
Polygenic Traits
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Single Nucleotide Polymorphisms-SNPs
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...

